U.S. FDA grants priority review to Roche's bispecific antibody Glofitamab

Österreich Nachrichten Nachrichten

U.S. FDA grants priority review to Roche's bispecific antibody Glofitamab
Österreich Neuesten Nachrichten,Österreich Schlagzeilen
  • 📰 Reuters
  • ⏱ Reading Time:
  • 15 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 97%

Roche announced on Friday the U.S. Food and Drug Administration has granted priority review to the Swiss pharmaceutical company's bispecific antibody Glofitamab.

The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020.

Arnd Wiegmann/File Photoannounced on Friday the U.S. Food and Drug Administration has granted priority review to the Swiss pharmaceutical company's bispecific antibody Glofitamab.The FDA is expected to make a decision on approval of the cancer immunotherapy by July 1, 2023.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

Reuters /  🏆 2. in US

Österreich Neuesten Nachrichten, Österreich Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Abortion pills for early pregnancy can be dispensed at pharmacies, FDA saysAbortion pills for early pregnancy can be dispensed at pharmacies, FDA saysBrick-and-mortar pharmacies, including chains like CVS and Walgreens, that get certified in the FDA's program and agree to accept prescriptions from certified providers will be able to dispense mifepristone. Patients will still need a prescription.
Weiterlesen »

FDA finalizes rule expanding availability of abortion pillsFDA finalizes rule expanding availability of abortion pillsU.S. health officials have finalized a rule change that broadens availability of abortion pills to many more pharmacies, including large chains and mail-order companies.
Weiterlesen »

FDA expands availability of abortion pillsFDA expands availability of abortion pillsThe FDA has finalized a rule change that broadens the availability of abortion pills to many more pharmacies, including large chains and mail-order companies.
Weiterlesen »

FDA finalizes rule expanding availability of abortion pillsFDA finalizes rule expanding availability of abortion pillsU.S. health officials have finalized a rule change that broadens availability of abortion pills to many more pharmacies, including large chains and mail-order companies.
Weiterlesen »

'Much-Welcome Step': FDA Rule Change Will Let Retail Pharmacies Offer Abortion Pills'Much-Welcome Step': FDA Rule Change Will Let Retail Pharmacies Offer Abortion PillsThe Food and Drug Administration late Tuesday formalized a regulatory change that will allow retail pharmacies in the U.S. to dispense abortion pills for the first time, removing a major barrier to access as Republican lawmakers wage all-out war on abortion throughout the country.
Weiterlesen »

FDA says it will greenlight pharmacies to fill prescriptions for abortion pillFDA says it will greenlight pharmacies to fill prescriptions for abortion pillThe FDA is relaxing the rules on the abortion pill mifepristone, saying pharmacies can now fill prescriptions for the drug so long as they become certified to do so.
Weiterlesen »



Render Time: 2025-03-13 10:00:40